MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Mitochondrial and autophagy alteration in a new fatty acid hydroxylase-associated neurodegeneration (FAHN) model

    F. Mandik, S. Misera, Y. Kanana, B. Wilken, C. Klein, M. Vos (Luebeck, Germany)

    Objective: Establishing a FAHN Drosophila model to identify cellular disease mechanisms. Background: Fatty acid hydroxylase-associated neurodegeneration (FAHN) is an early-onset neurodegenerative disease that manifests brain…
  • 2022 International Congress

    The mitochondrial risk score and lifestyle factors are associated with age at onset in LRRK2 p.Gly2019Ser Parkinson’s disease.

    T. Lüth, C. Gabbert, P. Lajer, I. König, A. Caliebe, S. Koch, B-H. Laabs, F. Hentati, S. Sassi, R. Amouri, C. Klein, A. Grünewald, M. Farrer, J. Trinh (Lübeck, Germany)

    Objective: To investigate the relationship between a mitochondrial risk score (MRS), lifestyle and age at onset (AAO) in LRRK2 G2019S Parkinson’s disease (PD). Background: PD…
  • 2022 International Congress

    A Phase 1b study to test the safety, pharmacokinetics, and pharmacodynamics of a novel inflammasome inhibitor in early-stage Parkinson’s disease: Rationale and study design

    G. D'Urso, A. Thomann, J. Anzures-Cabrera, B. Zinnhardt, B. Ricci, M. Marchesi, V. Machado, E. Mracsko, N. Pavese, K. Marek, K. Brockmann, T. Simuni, N. Milani Muelhardt, G. Pagano (Basel, Switzerland)

    Objective: To describe the study design of a Phase 1b to test the safety, pharmacokinetics, and pharmacodynamics of a novel inflammasome inhibitor in individuals with…
  • 2022 International Congress

    Machine learning algorithms for classification and analysis of pen-on-paper Archimedes spirals

    R. Anandapadmanabhan, A. Vishnoi, D. Biswas, A. Srivastava, D. Joshi, A. Mahabal, R. Rajan (New Delhi, India)

    Objective: To classify tremor syndromes from freely hand drawn pen-on-paper Archimedes spirals using classical machine learning techniques. Background: Spiral drawings (Archimedean) are commonly used in…
  • 2022 International Congress

    Long-term Safety of Medical Cannabis in Parkinson’s disease: a retrospective case-control study

    T. Goldberg, Y. Redlich, T. Fay-Karmon, S. Hassin-Baer, S. Anis (Tel Aviv, Israel)

    Objective: This study aims to evaluate the effects of long-term treatment with medical cannabis (MC) on the course of Parkinson’s disease (PD), with a focus…
  • 2022 International Congress

    Machine learning-based classification of SCA1, SCA2, and Healthy controls using graph features

    A. Indoria, S. Bhardwaj, AS. Sunny, S. Hegde, N. Kamble, J. Saini, R. Yadav, PK. Pal, RD. Bharath (Bengaluru, India)

    Objective: To differentiate genetic variants of spinocerebellar ataxia (SCA1 and SCA2) and healthy controls using machine learning on resting-state functional Magnetic Resonance Imaging graph features.…
  • 2022 International Congress

    Magnetic Resonance Image-guided high-intensity focused ultrasound (MRIgFUS) subthalamotomy in Spanish Parkinson’s disease (PD) patients.

    M. Campins-Romeu, R. Baviera-Muñoz, C. Morata-Martinez, I. Sastre-Bataller, R. Conde-Sardon, A. Gutierrez-Martin, I. Martinez-Torres (Valencia, Spain)

    Objective: To describe our preliminary results of MRIgFUS subthalamotomy in two PD patients. Background: MRIgFUS thalamotomy has become the preferred surgical approach for refractory essential tremor…
  • 2022 International Congress

    Relationship between cholinergic basal forebrain volume and short-latency sensory afferent inhibition in Parkinson’s disease with varying degrees of cognitive performance

    JF. Martín-Rodríguez, P. Franco Rosado, E. Iglesias Camacho, AM. Castellano-Gerrero, MA. Labrador-Espinosa, B. Villarreal, L. Muñoz-Delgado, D. Macías-García, P. álvarez Toledo, M. San Eufrasio, M. Reina Castillo, S. Jesús, A. Adarmes-Gómez, F. Carrillo, MJ. Grothe, P. Mir (Sevilla, Spain)

    Objective: To assess the relationship between volumetric measures of cholinergic basal forebrain (CBF) degeneration and short-latency sensory afferent inhibition (SAI) in Parkinson’s disease (PD). Background:…
  • 2022 International Congress

    Bilateral Magnetic Resonance Imaging-Guided Focused Ultrasound Thalamotomy in Medication-Resistant Essential Tremor Treatment.

    O. Kachemaeva, R. Galimova, D. Krekotin, Y. Sidorova, N. Mukhamadeeva, G. AKHMADEEVA. (Ufa, Russian Federation)

    Objective: To assess the efficacy and safety of bilateral magnetic resonance imaging-guided focused ultrasound thalamothomy for medication refractory essential tremor in prospective observation of two…
  • 2022 International Congress

    Short-latency afferent inhibition for the assessment of cholinergic degeneration in Parkinson’s disease

    E. D'Angremont, I. Zijdewind, S. Vander Zee, E. de Vries, T. van Laar, I. Sommer (Groningen, Netherlands)

    Objective: Our objective is to assess how well short-latency afferent inhibition (SAI) represents cortical cholinergic system integrity in patients with Parkinson’s disease (PD), using cholinergic…
  • « Previous Page
  • 1
  • …
  • 485
  • 486
  • 487
  • 488
  • 489
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley